Procter & Gamble (PG) Earnings Date & Reports

Key Takeaways

• Net sales rose 4% year over year to $23.28 billion, beating the roughly $22.8 billion consensus estimate.
• Core (adjusted) earnings per share of $2.00 topped the $1.88 analyst estimate and grew 1% from the prior year.
• Organic sales increased 4%, with every product category growing and volume up 2.4%.
• Core gross margin fell 150 basis points to 50%, pressured by higher commodity costs.
• P&G raised its all-in sales growth outlook to 2%–4% while keeping its core EPS guidance of $6.89 to $7.11.

Earnings Context and Why It Matters

Procter & Gamble, the consumer goods giant behind brands such as Tide, Pampers, Gillette, and Pantene, delivered its fiscal first-quarter 2027 results on October 22, 2026, for the three months ended September 30, 2026. The report matters because P&G is widely viewed as a bellwether for consumer staples and household spending. After a stretch of weak volume as shoppers traded down, investors were watching closely for signs of a demand recovery. The quarter showed broad-based top-line momentum, but also a familiar challenge: rising input costs squeezing margins. The results, and the company's updated outlook, help clarify whether P&G can sustain growth while protecting profitability.

Reported Results

P&G reported net sales of $23.28 billion, up 4% from $22.39 billion a year earlier and ahead of the roughly $22.8 billion analysts expected. Organic sales, which strip out currency moves and acquisitions and divestitures, rose 4%, driven by volume growth of 2.4%—a notable rebound after fiscal 2026 produced just one quarter of volume growth.

On the bottom line, net earnings attributable to Procter & Gamble were $4.73 billion, or $1.97 per share under generally accepted accounting principles (GAAP), down slightly from $4.75 billion, or $1.95 per share, a year ago. Core earnings per share (EPS), which exclude restructuring and other one-time items, came in at $2.00, up 1% and above the $1.88 consensus.

Growth was broad-based. Beauty led with organic sales up 5.4%, followed by Fabric & Home Care (up 4.8%) and Grooming (up 4.5%), while Baby, Feminine & Family Care and Health Care grew 3% and 2.7%, respectively. However, profitability was under pressure: core gross margin declined 150 basis points (one basis point equals one-hundredth of a percentage point) to 50%, and core operating margin slipped 80 basis points to 25.9%, reflecting higher commodity and transportation costs.

For the full fiscal year, P&G raised its all-in sales growth outlook to 2%–4% from 1%–3%, citing its completed $3.8 billion acquisition of health-and-wellness brand Thorne on October 1, 2026. The company reiterated organic sales growth of 1%–3% and core EPS of $6.89 to $7.11.

AI Screener

For investors looking to spot similar earnings-driven opportunities, Tickeron's AI Screener offers an AI-powered stock and ETF discovery tool designed to help traders filter the market by technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener can help identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore the AI Screener to streamline your research process.

Market Reaction and Investor Sentiment

Investors responded positively to the results. P&G shares rose more than 5% in early trading on October 22, putting the stock on track for its largest single-day gain since March 2020. The rally reflected relief that volume growth had returned across categories and that the company topped estimates on both sales and earnings, even as it flagged rising input costs. Sentiment was further supported by the upgraded all-in sales guidance and management's comments that the strong start keeps P&G on track to hit its full-year ranges. Still, analysts noted the competitive environment remains "intense" and that a bifurcated consumer—higher-income shoppers trading up while lower-income households seek value—continues to shape demand.

Forward Outlook and Key Factors to Monitor

The biggest near-term watch item is cost inflation. P&G expects a roughly $1.4 billion after-tax headwind from commodity, energy, and transportation costs in fiscal 2027, and management said it plans to offset part of that through productivity savings and innovation-led pricing rather than blunt price increases.

Investors should also track whether the volume rebound is sustainable. P&G reported volume growth of 2.4% this quarter after largely flat or negative volume trends in fiscal 2026. Continued share gains among top U.S. retailers—where more than 70% of its largest customers are now holding or growing share—will be a key signal of that durability.

Finally, the integration of Thorne, which closed on October 1, 2026, will shape the sales outlook and may open new growth avenues in health and wellness. Margin progression, free cash flow productivity, and the company's ability to maintain its $6.89 to $7.11 core EPS guidance while navigating currency swings and geopolitical uncertainty round out the factors worth monitoring in the quarters ahead.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations